Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial. [electronic resource]
- Journal of digestive diseases Oct 2019
- 547-556 p. digital
Adult Cognition--drug effects Female Gastrointestinal Agents--therapeutic use Gastrointestinal Microbiome--drug effects Hepatic Encephalopathy--drug therapy Humans Lactulose--therapeutic use Liver Cirrhosis--complications Male Middle Aged Quality of Life Time Factors Treatment Outcome